| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 777,504 | 853,069 | 879,439 | 850,067 | | Cost of Revenue | 137,232 | 173,523 | 165,557 | 163,604 | | | Gross Profit | 640,272 | 679,546 | 713,882 | 686,463 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 369,319 | 390,625 | 359,513 | 345,945 | | Non Recurring | 716,665 | 242,563 | 115,395 | 281 | | Others | 504,901 | 614,131 | 108,151 | 177,146 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (950,613) | (567,773) | 130,823 | 163,091 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (950,613) | (567,773) | 130,823 | 163,091 | | Interest Expense | 27,695 | 43,235 | 78,092 | 74,585 | | Income Before Tax | (978,308) | (611,008) | 52,731 | 88,506 | | Income Tax Expense | (151,727) | (126,512) | 11,214 | 22,037 | | Minority Interest |
-
| 1,520 | (3,757) | 5,729 | | | | Net Income From Continuing Ops | (826,581) | (482,976) | 37,760 | 72,198 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (826,581) | (482,976) | 37,760 | 72,198 | | Preferred Stock And Other Adjustments | (25,746) | (15,108) | (4,409) | (2,454) | | | Net Income Applicable To Common Shares | ($852,327) | ($498,084) | $33,351 | $69,744 |
|
0.45% Nasdaq 
0.20%
Income Statement
